Prediction of gestational diabetes mellitus by first trimester serum secreted frizzle-related protein-5 levels

References

• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013;36:S67–74
   PubMed Web of Science ®Google Scholar
• Jovanovic L, Pettitt DJ. Gestational diabetes mellitus. JAMA 2001;286:2516–18
   PubMed Web of Science ®Google Scholar
• Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25:1862–8
   PubMed Web of Science ®Google Scholar
• Buchanan TA, Xiang AH, Page KA. Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol 2012;8:639–49
   PubMed Web of Science ®Google Scholar
• Langer O, Yogev Y, Most O, Xenakis EM. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol 2005;192:989–97
   PubMed Web of Science ®Google Scholar
• Landon MB, Spong CY, Thom E, et al. A multicenter randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361:1339–48
   PubMed Web of Science ®Google Scholar
• Walsh JM, McGowan CA, Mahony R, et al. Low glycaemic index diet in pregnancy to prevent macrosomia (ROLO study): randomized control trial. BMJ 2012;345:e5605
   PubMed Web of Science ®Google Scholar
• Harrison CL, Lombard CB, East C, et al. Risk stratification in early pregnancy for women at increased risk of gestational diabetes. Diabetes Res Clin Pract 2015;107:61–8
   PubMed Web of Science ®Google Scholar
• Wolf M, Sandler L, Hsu K, et al. First trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 2003;26:819–24
   PubMed Web of Science ®Google Scholar
• Bao W, Baecker A, Song Y, et al. Adipokine levels during the first or early second trimester of pregnancy and subsequent risk of gestational diabetes mellitus: a systematic review. Metabolism 2015;64:756--64
   Google Scholar
• Ferreira AF, Rezende JC, Vaikousi E, et al. Maternal serum visfatin at 11–13 weeks of gestation in gestational diabetes mellitus. Clin Chem 2011;57:609–13
   PubMed Web of Science ®Google Scholar
• Eleftheriades M, Papastefanou I, Lambrinoudaki I, et al. Elevated placental growth factor concentrations at 11–14 weeks of gestation to predict gestational diabetes mellitus. Metabolism 2014;63:1419–25
   PubMed Web of Science ®Google Scholar
• Torry DS, Ahn H, Barnes EL, Torry RJ. Placenta growth factor: potential role in pregnancy. Am J Reprod Immunol 1999;41:79–85
   PubMed Web of Science ®Google Scholar
• Chang SC, Vivian Yang WC. Hyperglycemia induced altered expressions of angiogenesis associated molecules in the trophoblast. Evid Based Complement Alternat Med 2013;2013:457971
   PubMed Web of Science ®Google Scholar
• Calderon IM, Damasceno DC, Amorin RL, et al. Morphometric study of placental villi and vessels in women with mild hyperglycemia or gestational or overt diabetes. Diabetes Res Clin Pract 2007;78:65–71
   PubMed Web of Science ®Google Scholar
• Herder C, Carstensen M, Ouwens DM. Anti-inflammatory cytokines and risk of type 2 diabetes. Diabetes Obes Metab 2013;15:39–50
   PubMed Web of Science ®Google Scholar
• Almario RU, Karakas SE. Roles of circulating Wnt-signalling proteins and Wnt-inhibitors in human adiposity, insulin resistance, insulin secretion and inflammation. Horm Metab Res 2015;47:152–7
   PubMed Web of Science ®Google Scholar
• Sonderegger S, Husslein H, Leisser C, Knofler M. Complex expression pattern of Wnt ligands and frizzled receptors in human placenta and its trophoblast subtypes. Placenta 2007;28:97–102
   PubMed Web of Science ®Google Scholar
• Hu W, Li L, Yang M, et al. Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans. J Clin Endocrinol Metab 2013;98:290–8
   PubMed Web of Science ®Google Scholar
• Hu Z, Deng H, Qu H. Plasma Sfrp-5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance. Diabetes Res Clin Pract 2013;99:391–5
   PubMed Web of Science ®Google Scholar
• Carstensen M, Herder C, Kempf K, et al. Sfrp5 correlates with insulin resistance and oxidative stress. Eur J Clin Invest 2013;43:350–7
   PubMed Web of Science ®Google Scholar
• Xu Y, Jin B, Sun L, et al. The expression of FoxO1 in placenta and omental adipose tissue of gestational diabetes mellitus. Exp Clin Endocrinol Diabetes 2014;122:287–94
   PubMed Web of Science ®Google Scholar
• Yilmaz H, Celik HT, Namuslu M, et al. Benefits of the neutrophil-to-lymphocyte ratio for the prediction of gestational diabetes mellitus in pregnant women. Exp Clin Endocrinol Diabetes 2014;122:39–43
   PubMed Web of Science ®Google Scholar
• Aktas G, Alcelik A, Ozlu T, et al. Association between omentin levels and insulin resistance in pregnancy. Exp Clin Endocrinol Diabetes 2014;122:163–6
   PubMed Web of Science ®Google Scholar
• Canivell S, Rebuffat S, Ruano EG, et al. Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls. Diabetes Metab Res Rev 2015;31:212–19
   PubMed Web of Science ®Google Scholar
• Schulte DM, Muller N, Neumann K, et al. Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects. PLoS One 2012;7:e32437
   PubMed Web of Science ®Google Scholar
• Watanabe N, Morimoto S, Fujiwara T, et al. Prediction of gestational diabetes mellitus by soluble (pro)renin receptor during the first trimester. J Clin Endocrinol Metab 2013;98:2528–35
   PubMed Web of Science ®Google Scholar
• Bokuda K, Ichihara A. Possible contribution of (pro)renin receptor to development of gestational diabetes mellitus. World J Diabetes 2014;5:912–16
   PubMedGoogle Scholar
• Cruciat CM, Ohkawara B, Acebron SP, et al. Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling. Science 2010;327:1269–76
   Web of Science ®Google Scholar
• Buechling T, Bartscherer K, Ohkawara B, et al. Wnt/Frizzled signaling requires dPRR, the Drosophila homolog of the prorenin receptor. Curr Biol 2010;20:1263–8
   PubMed Web of Science ®Google Scholar